Sale!

HMBS Gene Acute Intermittent Porphyria Genetic Test

Original price was: $700.Current price is: $500.

-29%

The HMBS Gene Acute Intermittent Porphyria NGS Genetic DNA Test is a comprehensive genetic analysis that detects mutations in the HMBS gene responsible for Acute Intermittent Porphyria (AIP). This advanced next-generation sequencing test identifies specific genetic variations that disrupt heme production, leading to this rare metabolic disorder. The test provides crucial diagnostic information for individuals experiencing unexplained abdominal pain, neurological symptoms, or psychiatric manifestations. With results available in 3-4 weeks, this $500 USD test offers definitive diagnosis, enabling proper management and prevention of acute attacks. Genetic counseling is recommended before testing to understand family implications and create a comprehensive pedigree analysis.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

HMBS Gene Acute Intermittent Porphyria NGS Genetic DNA Test

Comprehensive Genetic Testing for Acute Intermittent Porphyria

Acute Intermittent Porphyria (AIP) is a rare inherited metabolic disorder affecting heme production, the essential component of hemoglobin. Our HMBS Gene NGS Genetic DNA Test represents the gold standard in genetic diagnostics for this complex condition, utilizing cutting-edge Next-Generation Sequencing technology to provide definitive answers for patients and families affected by this challenging disorder.

What This Advanced Genetic Test Detects

The HMBS Gene Acute Intermittent Porphyria NGS Genetic DNA Test specifically analyzes the hydroxymethylbilane synthase (HMBS) gene for pathogenic mutations that disrupt normal heme biosynthesis. This comprehensive analysis identifies:

  • Point mutations affecting enzyme function
  • Insertion/deletion variants disrupting gene structure
  • Missense and nonsense mutations altering protein production
  • Splice site variants affecting mRNA processing
  • Regulatory region mutations impacting gene expression

Who Should Consider This Genetic Test

This specialized genetic test is recommended for individuals experiencing symptoms suggestive of Acute Intermittent Porphyria or those with a family history of the condition. Key indications include:

  • Unexplained Severe Abdominal Pain: Recurrent, intense abdominal discomfort without clear gastrointestinal cause
  • Neurological Symptoms: Peripheral neuropathy, muscle weakness, or seizures
  • Psychiatric Manifestations: Anxiety, depression, hallucinations, or confusion
  • Autonomic Nervous System Issues: Tachycardia, hypertension, or sweating episodes
  • Family History: Known AIP in relatives or unexplained similar symptoms in family members
  • Medication Sensitivity: Adverse reactions to certain drugs known to trigger porphyria attacks

Significant Benefits of Genetic Testing

Undergoing the HMBS Gene Acute Intermittent Porphyria NGS Genetic DNA Test provides numerous advantages for patients and healthcare providers:

  • Definitive Diagnosis: Confirm or rule out AIP with high accuracy
  • Personalized Treatment Planning: Develop targeted management strategies based on genetic findings
  • Family Risk Assessment: Identify at-risk relatives for proactive monitoring
  • Prevention of Acute Attacks: Implement lifestyle modifications to avoid triggering factors
  • Reproductive Planning: Understand inheritance patterns for family planning decisions
  • Reduced Diagnostic Uncertainty: Eliminate unnecessary medical procedures and misdiagnoses

Understanding Your Test Results

Our comprehensive genetic report provides clear, actionable information to guide your healthcare journey:

  • Positive Result: Indicates the presence of a pathogenic HMBS gene mutation confirming AIP diagnosis. This enables implementation of preventive measures, appropriate treatment protocols, and family screening recommendations.
  • Negative Result: Suggests absence of known HMBS mutations associated with AIP, though clinical correlation with symptoms remains essential for comprehensive assessment.
  • Variant of Uncertain Significance: Identifies genetic changes with unclear clinical implications, requiring ongoing monitoring and potential family studies for clarification.
  • Carrier Status: For asymptomatic individuals with family history, identifies mutation carriers who may pass the condition to offspring.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700

Turnaround Time: 3 to 4 Weeks
Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card

Pre-Test Requirements

To ensure optimal testing outcomes, we recommend:

  • Comprehensive clinical history documentation
  • Genetic counseling session with our certified genetic counselors
  • Development of detailed pedigree chart mapping family members affected by porphyria symptoms
  • Discussion of potential implications for family members

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our network of certified collection centers ensures accessible genetic testing services nationwide.

Take Control of Your Genetic Health Today

Don’t let uncertainty about Acute Intermittent Porphyria control your life. Our HMBS Gene NGS Genetic DNA Test provides the clarity needed for proper diagnosis and management. With advanced NGS technology and expert genetic analysis, you can make informed decisions about your health and future.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your HMBS Gene Acute Intermittent Porphyria NGS Genetic DNA Test. Our dedicated genetic specialists are ready to guide you through every step of the testing process and help you understand your results for better health outcomes.